Erratum: Biomarker-Stratified Phase II Trial of Trastuzumab Rezetecan in Advanced Salivary Gland Carcinoma Across Cohorts With High and Low Human Epidermal Growth Factor Receptor 2 Expression.

Authors

Guang-Liang Chen, Yanjing Guo, Xin Liu, Ya'nan Yang, Youzhou Sang, Xueguan Lu, Si Sun, Xiao Shi, Yan Zhang, Tong-Zhen Chen, Ning Qu, Duo Wen, Xiao-Shuang Niu, Shu Dong, Yu Wang, Yulong Wang, Jiachen Wang, Lu Zhang, Chaosu Hu, Qinghai Ji, Dongmei Ji

Published in

Journal of clinical oncology : official journal of the American Society of Clinical Oncology. Pages JCO2602254. Sep 16, 2026. Epub Sep 16, 2026.

PMID:
42748389
Bibliographic data and abstract were imported from PubMed on 17 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.